Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability
FDA released new draft product-specific guidances for vape and tobacco products, including revised recommendations for PMTA submissions. These guidances may affect how manufacturers demonstrate substantial equivalence or seek marketing orders.
Aforeworn detected this change in the Vape & Tobacco Retail Compliance space on July 6, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated High urgency. E-liquid manufacturers, vape shops, distributors, and any business submitting PMTAs or substantial equivalence reports. should confirm how it applies to their specific situation before acting. There is a time constraint attached: Comments due within 60 days of publication (by April 28, 2026).. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Vape & Tobacco Retail Compliance continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
FDA published new draft and revised draft product-specific guidances that update testing, labeling, and data requirements for certain tobacco products, including ENDS.
Who it affects
E-liquid manufacturers, vape shops, distributors, and any business submitting PMTAs or substantial equivalence reports.
What you must do
Review the new draft guidances to ensure any pending or future PMTA submissions comply with updated recommendations. Provide comments by the deadline if desired.
Deadline
Comments due within 60 days of publication (by April 28, 2026).
Never miss a change like this again
Aforeworn watches Vape & Tobacco Retail Compliance around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Vape & Tobacco Retail Compliance
- US FDA proposes rule to tighten oversight of foreign tobacco makers - KELO-AM
- Heated tobacco: FDA renews IQOS exposure-modification authorization - Vera Health
- FDA Authorizes Modified Risk Claims for ZYN Nicotine Pouches: A Landmark Step for Tobacco Harm Reduction - The National Law Review
- FDA Finally Issues Proposed Rule to Require Foreign Tobacco Manufacturers to Register Facilities and List Products - Tobacco Reporter
- FDA Proposal Would Allow Oversight of Foreign Manufacturers - Tobacco Reporter